Enterococcus casei bacteriophage, application thereof and target bacterium pest control method

The symbiotic bacteria of the fallopiana phage SP-1 isolated from the sewage was removed from the symbiotics of the fall armyworm, which solved the problem of insecticide resistance, significantly improved the effect of insecticides and slowed down the effect of insecticides. The development of drug resistance provides a sustainable pest management program.

CN119040276AActive Publication Date: 2024-11-29WESTLAKE UNIV

Patent Information

Application Number
CN202411263558.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-10
Publication Date
2024-11-29
Estimated Expiration
2044-09-10

AI Technical Summary

Technical Problem

Fallia meadow has become resistant to traditional bisamide insecticides, resulting in weakening of insecticide effects and increasing use of chemical agents, forming a vicious cycle that threatens the ecological environment and human health.

Method used

The Enterococcus phage SP-1, isolated from sewage, can efficiently and specifically remove the symbiotic bacteria Enterococcus casseliflavus EMBL-3 in the intestines of the larvae of Fatella meadow, reducing its number and insecticide in pests and insecticide. agent resistance.

Benefits of technology

It significantly improves the control effect of insecticides on pests, increases the pest mortality rate by more than 50%, slows down the generation of drug resistance, provides a long-term and sustainable pest management plan, and reduces the use of chemical insecticides.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119040276A_ABST
    Figure CN119040276A_ABST
Patent Text Reader

Abstract

The invention discloses an enterococcus casei bacteriophage, application thereof and a target bacterium pest control method. Enterococcus casei is a kind of probiotics commonly co-generated in lepidoptera pests. The preservation name of the bacteriophage is Enterococcus cassiae phage SP-1, the preservation unit of the bacteriophage is China Center for Type Culture Collection, the preservation date of the bacteriophage is July 22, 2024, and the preservation number of the bacteriophage is CCTCC M 20241620. The bacteriophage is identified as a Caudovirus bacteriophage through genome sequencing, and the Caudovirus bacteriophage is named as SP-1. According to the technology, the carrying capacity of probiotics in pests is reduced by utilizing the targeted removal capacity of the phage on the pest probiotics, so that the prevention and treatment effect of the insecticide on the pests is improved. The technology is helpful to have further research and development and farmland application prospects in the fields of agricultural pest control, novel green biological insecticide development and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a target bacteria pest control technology, in particular to an Enterococcus casei bacteriophage, an application thereof and a target bacteria pest control method. Background Art

[0002] The fall armyworm is listed as a major agricultural pest on global alert by the Food and Agriculture Organization of the United Nations. Its spread is alarming and poses a serious threat to agricultural production. If effective prevention and control measures are not taken in time, it may lead to huge economic losses. Therefore, the prevention and control of the fall armyworm is urgent and has become an important part of ensuring food security. In the face of this challenge, traditionally, emergency treatment has relied on highly effective diamide insecticides such as chlorantraniliprole. However, with the widespread and improper use of these chemical agents, the fall armyworm has begun to show increasing resistance to pesticides. This not only weakens the insecticide effect, but may also force the agricultural sector to increase the amount of pesticides used, forming a vicious cycle and posing potential risks to the ecological environment and human health.

[0003] Previous studies have found that a symbiotic bacterium of fall armyworm, Enterococcus casseliflavus EMBL-3, can enhance the host's resistance to insecticides by degrading chlorantraniliprole, and it generally infects fall armyworm populations in the wild. Therefore, EMBL-3 has the potential to become a potential target for the management of fall armyworm resistance. The present invention reduces the beneficial symbiotic bacteria to the pest host in a targeted manner so as to maintain or improve the biological efficacy of the insecticide without significantly increasing the dosage of chemical agents. In this way, it can not only effectively reduce the cost of prevention and control of fall armyworm, but more importantly, it greatly slows down the rate of pest resistance, providing a strong guarantee for long-term and sustainable pest management. To this end, we isolated a bacteriophage Caudoviricetes SP-1 from sewage, which showed the ability to accurately remove specific symbiotic bacteria in the intestines of fall armyworm larvae, namely the enterococcal strain EMBL-3. Through in vivo and in vitro experiments, it was confirmed that SP-1 phage can act efficiently and specifically on EMBL-3, effectively reducing its number in the fall armyworm. At the same time, it can significantly reduce the insecticide resistance of the EMBL-3 infected pest host. This achievement not only reveals the great potential of phages in the biological control of agricultural pests, but also provides scientific basis and technical support for reducing the use of chemical pesticides, alleviating the problem of pest resistance, and protecting the ecological environment. Summary of the invention

[0004] The purpose of the present invention is to provide a caseiniferum Enterococcus phage, its application and target bacteria pest control method in view of the deficiencies of the prior art, which can effectively increase the control effect of pesticides on pests.

[0005] The technical solution adopted by the present invention is as follows:

[0006] A bacteriophage of Enterococcus casseliflavus, named as Enterococcus casseliflavus phage SP-1, deposited in China Center for Type Culture Collection, date of deposit: July 22, 2024, deposit number: CCTCC M20241620. The bacteriophage can be used in the preparation of insecticides or synergists of insecticides.

[0007] An insecticide synergist contains the Enterococcus casei phage as described above.

[0008] A pesticide comprising, in addition to the insecticidal active ingredient, the insecticide synergist as described above.

[0009] Furthermore, the insecticidal active ingredient is a diamide insecticide.

[0010] A targeted bacteria pest control method uses an isolated strain of probiotic bacteria of pests as a host bacterium, directionally separates a bacteriophage targeting the probiotic bacteria of pests, and uses the bacteriophage in combination with an insecticide to control the pests.

[0011] The beneficial effects of the present invention are:

[0012] The phage of the present invention is identified as Caudoviricetes phage through genome sequencing and named SP-1. The present invention utilizes the targeted elimination ability of the phage on probiotics of pests to reduce the load of probiotics in the pests, thereby increasing the control effect of the pesticide on the pests, and can significantly increase the mortality rate of pests by more than 50%. This technology has the prospect of further research and development and farmland application in the fields of agricultural pest control and development of new green biological pesticides. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] Figure 1 This is an image of bacteriophage SP-1 under a scanning transmission microscope.

[0014] Figure 2 This is the double-layer plate plaque image of bacteriophage SP-1.

[0015] Figure 3 This is the electrophoresis diagram of bacteriophage SP-1 nucleic acid extraction and identification.

[0016] Figure 4 This is the optimal infection multiplicity diagram of bacteriophage SP-1.

[0017] Figure 5 This is the one-step growth curve of bacteriophage SP-1.

[0018] Figure 6 The inhibition of EMBL-3 growth by bacteriophage SP-1.

[0019] Figure 7 The inhibitory ability of phages in the fall armyworm to EMBL-3.

[0020] Figure 8 The effect of bacteriophage SP-1 on the insecticide resistance of Spodoptera frugiperda infected with EMBL-3. DETAILED DESCRIPTION

[0021] The technical scheme of the present invention is further described in detail below in conjunction with the accompanying drawings and specific embodiments. If specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0022] Example 1 Isolation and identification of bacteriophage

[0023] Phage isolation: The phage was isolated from untreated domestic sewage, and the sewage source was Hangzhou Chengxi Sewage Treatment Plant. The sewage sample was centrifuged at 10,000 rpm for 10 minutes at 4°C to remove impurities. The supernatant was then filtered through 0.45μm and 0.22μm polyethersulfone (PES) membranes in turn to further remove bacterial cells, and the sample filtrate was stored at 4°C. Take 1mL of the host bacteria EMBL-3 cultured to the logarithmic phase (OD600~0.5), add 7mL of the sample filtrate and 4mL of 3 times BHI fresh liquid culture medium, mix well, and culture overnight at 37°C and 180r / min. The phage enrichment solution cultured overnight was centrifuged at 4°C and 12,000rpm for 5min, and the supernatant was filtered with a 0.22μm PES membrane to obtain fresh phage lysate. The enriched sample filtrate of EMBL-3 phage was gradiently diluted with SM buffer. In each dilution gradient, 100 μL of filtrate and 400 μL of host bacteria were added to 4.5 mL of 0.5% BHI semi-solid medium and mixed evenly. The mixture was poured onto the solid medium and spread evenly until the semi-solid medium solidified. The mixture was then inverted and cultured in a 37°C incubator overnight.

[0024] Phage purification: Use the double-layer plate method to isolate and purify phages from single plaques. According to the morphology of the plaques, use a sterile toothpick or a 10μL pipette tip to pick up the plaques and transfer them to 1mL SM buffer. Take 0.1mL of the host bacteria EMBL-3 cultured to the logarithmic phase (OD600 ~ 0.5), add 0.7mL of SM buffer containing phage and 0.4mL of 3 times BHI fresh liquid medium, mix well, and culture overnight at 37°C and 180r / min. Repeat the steps of phage enrichment and isolation, and perform 3 rounds of purification to obtain a single phage with consistent plaque characteristics on the plate.

[0025] Phage storage: Mix fresh phage lysis solution and 50% sterile glycerol in a ratio of 1:1 and store at -80℃. Store fresh lysis solution at 4℃.

[0026] Titer determination: The double-layer plate method is used to evaluate the titer of the phage. First, pour LB solid culture medium into a sterile culture dish as the bottom layer, then mix the appropriately diluted phage with the host bacteria cultured to the logarithmic phase, and after heat preservation and adsorption, add semi-solid BHI culture medium cooled to about 45°C, quickly mix and spread on the plate as the upper layer, and invert the plate after it cools and solidifies. Observe the number of plaques that appear on the plates with different dilutions, and select the plates with 30 to 300 plaques on the culture dish to calculate the titer of the original solution phage. The formula for calculating the phage titer is: plaque forming unit (PFU / mL) = number of plaques × dilution factor × 10.

[0027] Phage morphology observation: The morphology of phage was observed using a transmission electron microscope (TEM). 8 10 μL of phage lysis solution (PFU / mL) was dropped onto the copper mesh carbon film, and the front side was left to stand for 5 minutes, and then the excess sample was removed with filter paper. Then 10 μL of 2% (W / V) phosphotungstic acid staining solution was dropped onto the front side of the copper mesh for negative staining for 1 minute, and the excess sample was immediately removed with filter paper, and the copper mesh was allowed to dry naturally. The morphology of phages was observed using a Talos L120C G2 120kV transmission electron microscope.

[0028] After phages were stained with 2% phosphotungstic acid, Figure 1 Transmission electron microscopy observations showed that its overall morphology was tadpole-shaped, with a regular polyhedron head with a diameter of about 60-80nm and a long tail of about 150nm. It belongs to the Caudoviricetes order.

[0029] Phage plaque morphology: The phage plaque morphology was observed using a double-layer plate. Figure 2 As shown, the plaques are round, transparent plaques with halos on the edges, and are about 2 mm in diameter.

[0030] Phage nucleic acid extraction, identification and genome determination: Take 20mL of phage lysis solution (centrifugal filtered bacteria), add PEG8000 and NaCl for precipitation, let stand at 4℃ for 16h, centrifuge at 10000r / min for 20min to obtain the precipitate, and resuspend the phage precipitate with 400μL SM buffer (Tris-HCl / MgSO4 / NaCl / H2O, pH 7.5). Add 8U DNaseI, 20U RNase A, and 40μL 10x DNA buffer to the resuspended sample and mix well, and incubate at 37℃ for 1h for enzyme digestion. The genome of the treated sample was extracted using the MiniBEST Viral RNA / DNA Extraction Kit Ver.5.0 (TaKaRa) kit. The genomic DNA was digested and identified using DNase I and RNase I, and 1% agarose was used for gel electrophoresis to detect the genetic material components of the phage. Figure 3 The results showed that DNase I could completely digest the genetic material of the phage, proving that its genetic material was DNA.

[0031] The concentration of the extracted genome was quantified using a Qubit fluorometer (Thermo Fisher Scientific). The whole genome library was constructed using Nextera TM DNA Library Preparation Kits (Illumina) library preparation kit, library concentration quantification using Qubit, and library construction quality inspection using Agilent 4150 TapeStation system. Library samples were sequenced using Illumina MiSeq sequencing platform. Sequencing results were assembled using SPAdes software.

[0032] Online website based PhageScope (deepomics.org) , the phage is predicted to be a Caudoviricetes phage, named SP-1. The phage is deposited under the name Enterococcus casseliflavusphage SP-1, deposited in China Center for Type Culture Collection, date of deposit: July 22, 2024, deposit number: CCTCC M 20241620.

[0033] Example 2 Optimal multiplicity of infection (MOI) determination

[0034] The optimal infection multiplicity was used to determine the infection conditions under which the phage could produce the maximum number of phage generations when infecting the host bacteria. 9 PFU / mL) and the host bacteria EMBL-3 cultured to logarithmic phase (~10 8CFU / mL) were mixed at a ratio of SP-1 / EMBL-3 = 0.001, 0.01, 0.1, 1, 10, 100, and cultured overnight in an incubator at 37°C, 180 rpm / min. The final phage titer was determined using a double-layer plate. The highest titer was the optimal infection multiplicity of the phage. Figure 4 As shown, the experimental results show that the optimal infection multiplicity is 0.1.

[0035] Example 3 One-step growth curve determination:

[0036] Add 2 mL of SP-1 and fresh EMBL-3 value-added liquid with an MOI ratio of 0.1 / 0.01, and mix thoroughly. Incubate at 37°C for 10 min, centrifuge at 11000g for 1 min, discard the supernatant, wash once with 10 mL of LB broth, and discard the supernatant. Suspend the precipitate with 10 mL of preheated LB broth and mix thoroughly, and quickly place it in a 37°C shaker with 180 rpm shaking culture. Take out 150 μL at 0, 2, 5, 10, 20, 30, 40, 50, 60, 90, 120, 180, and 240 min, centrifuge at 10000 rpm for 1 min, take 100 μL of the supernatant and dilute it, and determine the phage titer using the double-layer plate method. Use the infection time as the horizontal axis and the phage titer as the vertical axis to draw a one-step growth curve, such as Figure 5 As shown in a and b, at the optimal MOI (MOI = 0.1), the incubation period of the phage is shorter, with a breakthrough period of 0-90 min, and at an MOI of 0.01, the incubation period of the phage is 2-20 min.

[0037] Example 4 Inhibition of EMBL-3 growth by bacteriophage:

[0038] The purified bacteriophage SP-1 solution was mixed with 10 8 100 μL of each of the EMBL-3 cells at the logarithmic phase of CFU / mL were mixed in a 96-well plate. 8 CFU / mL logarithmic phase EMBL-3 was mixed with 100 μL LB liquid medium as a positive control, 200 μL LB liquid medium as a negative control, and 200 μL sterile water as a blank control. Three replicates were set for each group. The culture was shaken at 37°C and 180 rpm / min for 12 h in an ELISA reader, and the OD600 was measured every 0.5 h. The results were as follows: Figure 6 shown.

[0039] The results showed that when the MOI was greater than 10, SP-1 could significantly inhibit the proliferation of EMBL-3, and when the MOI was between 1-5, it delayed the logarithmic growth phase of EMBL-3, while when the MOI was below 1, it had little effect on the proliferation of EMBL-3.

[0040] Example 5 In vivo inhibition of EMBL-3 by bacteriophage:

[0041] A sterile fall armyworm strain was constructed by disinfecting the egg surface. When the sterile fall armyworm became 2-3 instar insects, they were fed feed containing EMBL-3 for 2 days, so that EMBL-3 colonized in the fall armyworm and reached a steady state. Subsequently, the experimental subjects were divided into two groups. One group of fall armyworms was fed feed containing SP-1 for 2 days, while the remaining group was fed feed without bacteriophages, also for 2 days. After the feeding experiment, the two groups of fall armyworms were dissected, and intestinal tissue and total DNA were extracted from them. The qRT-PCR method was used to detect the content of EMBL-3. Figure 7 As shown, the experimental results showed that compared with the control group fed with phage-free feed, the growth of symbiotic bacteria EMBL-3 in the fall armyworm in the experimental group fed with SP-1 was significantly inhibited.

[0042] Example 6 Effect of bacteriophage on insecticide resistance of fall armyworm:

[0043] Similar to Example 5, the surface disinfection method was also used to construct a sterile fall armyworm strain. When they became 2-3 instar insects, they were fed with feed containing EMBL-3 for 2 days, and then divided into two groups, one group continued to be fed with feed not containing bacteriophage for 2 days, and the other group was fed with feed containing bacteriophage for 2 days. After the feeding was completed, the two groups of fall armyworms were fed with feed containing the same concentration of chlorantraniliprole, and sterile normal feeding and sterile normal feeding groups were set up for bioassay. The Control group was a normal fall armyworm group, Sterilized was a constructed sterile fall armyworm strain, EMBL-3 was a sterile fall armyworm strain that was fed with EMBL-3 added to the feed, and SP-1 was a sterile fall armyworm strain that was fed with feed containing EMBL-3 and then fed with feed containing SP-1. The results are as follows: Figure 8 The experimental results showed that SP-1 could significantly reduce the increased insecticide resistance of the host EMBL-3.

[0044] The present invention uses the probiotic Enterococcus tyrosinum isolate of the pest fall armyworm as the host bacteria, directionally isolates the phage targeting the bacteria, and uses the phage in combination with insecticides to control the pests, which can effectively reduce the insecticide resistance of the fall armyworm, and significantly improve the mortality rate of the pests caused by insecticides. Obviously, the phage can be prepared as an insecticide synergist and applied in insecticides or target bacteria insecticides. The inventive concept can also be extended to the control of other pests.

[0045] The above-described embodiments are only some of the preferred solutions of the present invention, but they are not intended to limit the present invention. A person skilled in the relevant technical field may make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, any technical solution obtained by equivalent replacement or equivalent transformation falls within the protection scope of the present invention.

Claims

1. A bacteriophage of Enterococcus casseliflavus, named: Enterococcus casseliflavus phage SP-1, deposited by: China Center for Type Culture Collection, deposited on July 22, 2024, deposited on: CCTCC M 20241620.

2. Use of the Enterococcus casei phage as claimed in claim 1 in the preparation of insecticides or synergists of insecticides.

3. A pesticide synergist, characterized in that: Contains the Enterococcus casei phage as claimed in claim 1.

4. An insecticide, characterized in that: In addition to the insecticide active ingredients, the insecticide synergist as claimed in claim 3 is also contained.

5. The insecticide according to claim 4, characterized in that The insecticidal active ingredient is a diamide insecticide.

6. A method for controlling insects with target bacteria, characterized in that: The pest probiotic isolate is used as a host bacterium, a bacteriophage targeting the pest probiotic is directionally isolated, and the pest is controlled by combining the bacteriophage with an insecticide.

Citation Information

Patent Citations

  • Novel enterococcus faecium bacteriophage ent-FAP-4 and use for inhibiting enterococcus faecium proliferation of same

    CN110621776A

  • Immunogenic sequences from a phage tail length tape measure protein, bacteria expressing the same and their use in treating a cancer

    CN111954538A

  • Phage and medical application thereof in prevention and treatment of broiler endocarditis

    CN113215111A

  • Staphylococcus aureus phage and bacteriostatic application thereof

    CN113621584A

  • Broad-spectrum klebsiella pneumoniae bacteriophage as well as training method and application thereof

    CN116200345A

Cited By

  • Enterococcus casei and application thereof

    CN120137818A